Replay available

Dr. Reddy's Laboratories Ltd (RDY) Q1 2026 Earnings Call

Dr. Reddy's Laboratories Ltd (NYSE: RDY) Q1 2026 earnings conference call, held 2025-07-23. Replay captured from the company's public earnings webcast.

Wed, July 23, 2025 at 10:00 AMendedReplay
Dr. Reddy's Laboratories Ltd (RDY) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

N. V. Narsimhan

Chief Financial Officer

Erez Israeli

Chief Executive Officer

Madhav Varda

Analyst, Fidelity International

Dr. Harit Arman

Analyst, Avengers Park

Dr. B. Dilo

Analyst, Elara Capital

Vishal Manodali

Analyst, Motilal Oswal

Shyam Srinivasan

Analyst, Goldman Sachs

Aman Witt

Analyst, Acute Investment Management

Kunal Avesha

Analyst, Macquarie

Replay transcript excerpt

Good day, everyone, and welcome to the quarter one FI26 earnings call of Dr. Reddy's Laboratories Limited. I'm Aishwarya Sitaram, and I'm part of the Dr. Reddy's Congratulations team. I would like to indicate that all participants will be in the listen-only mode during the opening remarks, and there will be an opportunity for you to ask questions thereafter. Should you need any technical assistance during the call, please use the chat function in your Zoom application. Please note that the chats will not be monitored for any questions to the management. I now hand the conference over to Richa Parival. Thank you. Thank you, Aishwarya. Good morning, good evening, and a warm welcome to all. Thank you for joining us for Dr. Reddy's Q1 FY26 earnings conference call. We truly appreciate your time and participation. Joining us today are members of the leadership team, Mr. Iraz Israeli, our CEO, Mr. N.V. Narsimham, our CFO, and the IR team. Earlier today, we released our quarterly financial results. These are now available on our website for your reference. We'll begin the session with N.V. presenting an overview of the financial performance for the quarter. Following that, Evaze will provide his perspective on the business highlights and the strategic outlook. We will then move to the Q&A segment as mentioned by Aishwarya. Before we proceed, please note that today's call is the proprietary material of Dr. Reddy's laboratories and cannot be rebroadcasted or attributed in any media or press outlet without prior written consent from the company. This session is being recorded and both the replay and the transcript will be made available on our website shortly. All commentary and analysis during this call are based on our IFRS consolidated financial statements. In addition, the...

More from Dr. Reddy's Laboratories Ltd.